Tower Research Capital (TRC)’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $51.4K | Buy |
|
|||||
|
2025
Q1 | $11.5K | Buy |
|
|||||
|
2024
Q4 | $10.3K | Buy |
|
|||||
|
2024
Q3 | $9.42K | Sell |
|
|||||
|
2024
Q2 | $29.1K | Buy |
|
|||||
|
2024
Q1 | $3.05K | Sell |
|
|||||
|
2023
Q4 | $16.6K | Sell |
|
|||||
|
2023
Q3 | $35K | Buy |
|
|||||
|
2023
Q2 | $19.8K | Sell |
|
|||||
|
2023
Q1 | $81K | Buy |
|
|||||
|
2022
Q4 | $4K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $10K | Buy |
|
|||||
|
2021
Q4 | $10K | Buy |
|
|||||
|
2021
Q3 | $9K | Sell |
|
|||||
|
2021
Q2 | $20K | Buy |
|
|||||
|
2021
Q1 | $23K | Sell |
|
|||||
|
2020
Q4 | $29K | Buy |
|
|||||
|
2020
Q3 | $33K | Buy |
|